Changing how the important work gets done
“What Sanofi is doing is reducing its own internal research capacity,” he said. “The days when we locked all of our scientists up in a building and put them on a nice tree-lined campus are done. We will do less of our own research. We’re not going to get out of research. We believe we do certain things well in research but we want to work with more outside companies, startup biotechs, with universities.”
Chris Viehbacher, CEO of pharmaceutical company Sanofi recently stated that ” … big companies, and not just Big Pharma, big companies I believe, are not any good at doing innovation.” It seems Sanofi is moving to a more networked way of doing business. But to be more innovative, companies must first become open and transparent. Read more →














